Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Louna Regenerative is a biotechnology company based in Dubai, UAE, specializing in the development and commercialization of exosome-based regenerative therapies. The company focuses on harnessing the signaling potential of extracellular vesicles to promote tissue repair, cellular rejuvenation, and longevity. Louna's proprietary platform enables the isolation of high-purity exosomes, which are integrated into advanced products for aesthetic dermatology and hair restoration. Currently, the company offers commercial-grade exosome solutions for skin and hair while advancing a pipeline of therapeutic candidates for wound healing and other medical indications. As a pioneer in the Middle Eastern regenerative medicine landscape, Louna aims to bridge the gap between laboratory research and clinical application in the field of cellular communication.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LOUNA REGENERATIVE.